63 related articles for article (PubMed ID: 2329721)
1. [The frequency of patients with positive HIV-antibody in the various groups and the prognosis of these patients treated with SNMC].
Endo Y; Mamiya S; Iwamoto K; Niitsu H; Itoh T; Miura A
Rinsho Byori; 1990 Feb; 38(2):188-92. PubMed ID: 2329721
[TBL] [Abstract][Full Text] [Related]
2. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan].
Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y
Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699
[TBL] [Abstract][Full Text] [Related]
3. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection.
Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Imaizumi M; Tada K; Aihara M; Sawada Y; Yokoyama M
Tohoku J Exp Med; 1990 Oct; 162(2):183-93. PubMed ID: 2129071
[TBL] [Abstract][Full Text] [Related]
4. Effects of glycyrrhizin (SNMC: stronger Neo-Minophagen C) in hemophilia patients with HIV infection.
Mori K; Sakai H; Suzuki S; Sugai K; Akutsu Y; Ishikawa M; Seino Y; Ishida N; Uchida T; Kariyone S
Tohoku J Exp Med; 1989 May; 158(1):25-35. PubMed ID: 2781539
[TBL] [Abstract][Full Text] [Related]
5. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
[TBL] [Abstract][Full Text] [Related]
6. Detection of HIV infection in pulmonary tuberculosis patients.
Samuel NM; Alamelu C; Jagannath K; Rajan B
J Indian Med Assoc; 1996 Sep; 94(9):331-3. PubMed ID: 9019077
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
8. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection.
Numazaki K; Umetsu M; Chiba S
Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus (HIV)-positive and HIV-negative patients.
Jongwutiwes U; Sungkanuparph S; Kiertiburanakul S
Jpn J Infect Dis; 2008 Mar; 61(2):111-5. PubMed ID: 18362398
[TBL] [Abstract][Full Text] [Related]
10. A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification.
Nakashima H; Matsui T; Yoshida O; Isowa Y; Kido Y; Motoki Y; Ito M; Shigeta S; Mori T; Yamamoto N
Jpn J Cancer Res; 1987 Aug; 78(8):767-71. PubMed ID: 2443473
[TBL] [Abstract][Full Text] [Related]
11. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
[TBL] [Abstract][Full Text] [Related]
12. HIV seropositivity in children admitted with diarrhoea at Eldoret District Hospital, Kenya.
Esamai F; Buku GM
East Afr Med J; 1994 Oct; 71(10):631-4. PubMed ID: 7821240
[TBL] [Abstract][Full Text] [Related]
13. [Replication indexes of the human immunodeficiency virus: predictive value of viral culture and blood antigens].
Carton JA; Melón S; Maradona JA; de Oña M; Asensi V; Martínez A; Cárcaba V
Med Clin (Barc); 1994 May; 102(19):725-30. PubMed ID: 8041201
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of cancer chemotherapeutic agent-induced toxicity in postoperative breast cancer patients with glycyrrhizin (SNMC)].
Akimoto M; Kimura M; Sawano A; Iwasaki H; Nakajima Y; Matano S; Kasai M
Gan No Rinsho; 1986 Jul; 32(8):869-72. PubMed ID: 3091882
[TBL] [Abstract][Full Text] [Related]
15. HIV seroconversion without infection after receipt of adenovirus-vectored HIV type 1 vaccine.
Quirk EK; Mogg R; Brown DD; Lally MA; Mehrotra DV; DiNubile MJ; Robertson MN
Clin Infect Dis; 2008 Dec; 47(12):1593-9. PubMed ID: 18990058
[TBL] [Abstract][Full Text] [Related]
16. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
17. HIV seroprevalence in emergency department patients: Lagos University Teaching Hospital, Lagos, 1999.
Esan OA; Akanmu AS; Akinsete I
Niger Postgrad Med J; 2003 Jun; 10(2):71-5. PubMed ID: 14567038
[TBL] [Abstract][Full Text] [Related]
18. [Bronchial asthma due to Stronger Neo-Minophagen C].
Nakatsumi Y; Abe T; Nomura G; Fujimura M; Matsuda T
Nihon Kokyuki Gakkai Zasshi; 1998 Jul; 36(7):644-6. PubMed ID: 9805919
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
Goedert JJ;
Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of human immunodeficiency viruses in Africa.
Fleming AF
Biomed Pharmacother; 1988; 42(5):309-20. PubMed ID: 3191207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
